Pancreatic Cancer Research

ResearcherNorthwestern UniversityActive in the last 2 years

Aydın Eresen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9414-9986; OpenAlex author ID A5028951034. Sources: OpenAlex.

Their work

Papers
13 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2019: 4 papers · 2020: 5 papers · 2021: 2 papers · 2022: none · 2023: none · 2024: 2 papers

Papers 13

  1. Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review. Co-author DOI 10.21037/atm-23-1882↗
  2. Predicting and Monitoring Immune Checkpoint Inhibitor Therapy Using Artificial Intelligence in Pancreatic Cancer. Co-author DOI 10.3390/ijms252212038↗
  3. Detection of Immunotherapeutic Response in a Transgenic Mouse Model of Pancreatic Ductal Adenocarcinoma Using Multiparametric MRI Radiomics: A Preliminary Inve… Co-author DOI 10.1016/j.acra.2020.04.026↗
  4. Irreversible electroporation ablation overcomes tumor-associated immunosuppression to improve the efficacy of DC vaccination in a mice model of pancreatic canc… First author DOI 10.1080/2162402x.2021.1875638↗
  5. Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model. Co-author DOI 10.1016/j.jcyt.2019.12.001↗
  6. MRI radiomics for early prediction of response to vaccine therapy in a transgenic mouse model of pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12967-020-02246-7↗
  7. Dinaciclib prolongs survival in the LSL-Kras G12D/+ ; LSL-Trp53R172H/+ ; Pdx-1-Cre (KPC) transgenic murine models of pancreatic ductal adenocarcinoma. Co-author PMID 32269732↗
  8. Prediction of therapeutic outcome and survival in a transgenic mouse model of pancreatic ductal adenocarcinoma treated with dendritic cell vaccination or CDK i… Co-author PMID 32509212↗
  9. Effect of route of administration on the efficacy of dendritic cell vaccine in PDAC mice. First author PMID 33294276↗
  10. Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies. Co-author DOI 10.1016/j.prp.2019.152691↗
  11. Association of radiomic imaging features and gene expression profile as prognostic factors in pancreatic ductal adenocarcinoma. Co-author PMID 31396352↗
  12. Natural killer cell-based adoptive transfer immunotherapy for pancreatic ductal adenocarcinoma in a Kras LSL-G12D p53LSL-R172H Pdx1-Cre mouse model. Co-author PMID 31497356↗
  13. Dendritic cell immunotherapy induces anti-tumor effect in a transgenic mouse model of pancreatic ductal adenocarcinoma. Co-author PMID 31815046↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhuoli Zhang · 13 shared papers, 2019–2024 · strength 1.72
  2. Vahid Yaghmai · 11 shared papers, 2019–2024 · strength 1.52
  3. Jia Ying Yang · 10 shared papers, 2019–2021 · strength 1.18
  4. Al B. Benson · 4 shared papers, 2020–2021 · strength 0.49
  5. Zigeng Zhang · 2 shared papers, 2024 · strength 0.46
  6. Guangbo Yu · 2 shared papers, 2024 · strength 0.46
  7. Su Hu · 3 shared papers, 2020 · strength 0.32
  8. Su Hu · 2 shared papers, 2019–2020 · strength 0.21
  9. Liang Pan · 2 shared papers, 2019–2020 · strength 0.19
  10. Yumin Li · 1 shared paper, 2020 · strength 0.11
  11. Anna Junjie Shangguan · 1 shared paper, 2020 · strength 0.10
  12. Li Yu · 1 shared paper, 2019 · strength 0.09
  13. Su Hu · 1 shared paper, 2019 · strength 0.09
  14. Jingjing Xiao · 1 shared paper, 2019 · strength 0.08
  15. Ke Li · 1 shared paper, 2019 · strength 0.08
  16. Wei Chen · 1 shared paper, 2019 · strength 0.08
  17. Huaizhi Wang · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.